Clinical Trial: Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174349) titled 'Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery' on Sept. 12.

Brief Summary: The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Urinary Retention Postoperative

Intervention: DRUG: Uroselective alpha-1-adrenergic receptor antagonist

Subjects will receive Tamsulosin (0.4 mg daily) beginning 5 days prior to surgery and for the duration of the postop...